A “weighted” lottery program designed to ensure that people living in the most disadvantaged U.S. neighborhoods would be offered a scarce, potentially life-saving medication proved feasible in a large health system. The approach can improve equity in receipt of the drug by people disproportionately affected by disease, according to an analysis published today in JAMA Health Forum by University of Pittsburgh and UPMC scientist-clinicians.
Scientists at City of Hope have identified a cell metabolism process found in men with diabetes and metastatic prostate cancer that could one day lead to improved testing and treatments for Black men with these diseases.
More than 500 legislative proposals in 49 states are targeting trans people—predominantly youths—prompting fear among patients, healthcare providers, advocates, and legal experts that trans and gender nonconforming patients will be excluded from care.
At a glance, the 2023-24 U.S. News & World Report ranking for Best Hospitals for Cancer looks the way it always has—a list of premier institutions. You have to dig deeper to find changes in the way the closely watched 40-year-old ranking was put together and why these changes in methodology were made.
Wendy R. Brewster, MD, PhD, a compassionate clinician-scientist who focused her career on caring for women with gynecologic cancer and studying at-risk populations and the disparate mechanisms leading to poor outcomes in endometrial, ovarian, and cervical cancers, died of pancreatic cancer on July 24. She passed surrounded and supported by her family in Houston, where her sister lived.
A new center at Winship Cancer Institute of Emory University will focus research efforts on eliminating cancer disparities in Georgia and nationwide.
Cancer research centers conducting clinical trials could enroll more patients from underrepresented racial and ethnic groups by placing greater emphasis on relieving
In an era of intensifying judicial repudiation of evidence-based guidelines and deepening public mistrust toward science, America’s screening rate for cervical cancer has been declining.
St. Jude’s Path to a Bright Future, an HPV awareness and vaccination campaign with nearly 160 partners, is aimed at reducing that disease burden by targeting children in a crucial age range.
The standard of care in HPV vaccination may soon change if a one-dose regimen is found to be just as efficacious as two or three doses—once a large trial that NCI is conducting in Costa Rica, in young women ages 12 to 16, is ready to report final results in a few years. “We’ve done […]
